InProTher
Adaptive immune therapy capable of targeting immunosuppressive genes of ancient retroviruses
1
Funding Rounds
$6.5m
Money raised
Funding series
Funding Series Analysis
The company InProTher has raised a total of $6.5m in funding over 1 rounds.
Key Insights:
- InProTher May 2023 Seed Funding Round: $6.5m
InProTher May 2023 Seed Funding Round
$6.5m
Industries
InProTher is active in the following industries: